Recent news and appearances
News coverage, awards, and conference appearances from PlantPharm BioMed, Ltd.
Research on Plant-Based SARS-CoV-2 Vaccine to Be Presented at One Health Symposium
Dr. Richard Matner presented a research poster, “Plant-based, Feed-delivered SARS-CoV-2 Animal Vaccine,” at the International Symposium on One Health Research in Galveston, TX, building on a successful FDA-authorized human clinical trial of an orally administered plant-based Hepatitis B vaccine.
USDA APHIS Announces Major Award to PlantPharm BioMed to Develop Edible COVID Vaccine for Animals
The U.S. Department of Agriculture Animal and Plant Health Inspection Service awarded PlantPharm BioMed, Ltd. of Delavan, Wisconsin more than $900,000 to develop an edible vaccine deliverable via feeding stations for wild animals, feed rations for farmed animals, or vaccine-treats for pets — part of the One Health Initiative.
Innovations: PlantPharm BioMed Seeks to Combat Viruses with Plant-Based, Edible Vaccines
Coverage by Ashley Smart, originally published by BizTimes.
World Vaccine Congress Washington Past
Washington, D.C. — Richard Matner, Ph.D. discussed the pelletized feed vaccine for COVID-19 in farmed and migratory animals.
BIO International Convention Past
San Diego, CA — described as the largest and most comprehensive event for biotechnology, with over 20,000 industry leaders in attendance.
73rd Annual James Steele Conference on Diseases in Nature Transmissible to Humans Past
College Station, TX — sponsored by the Texas DSHS Zoonosis Control Branch and Texas Health Institute; Dr. Matner discussed the pelletized feed vaccine for COVID-19 in white-tailed deer.
UTMB One Health Symposium Past
Galveston, TX — “Improving Food Security and Resilience.”